PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-08-11

Date Title Company
11-Aug-2022 argenx Announces European Commission Approval of VYVGART™ (efgartigimod alfa-fcab) for the Treatment of Generalized Myasthenia Gravis argenx
11-Aug-2022 Electronic Stethoscope Market is projected to reach a valuation around US$ 369 Million in 2029 MARKITWIRED
11-Aug-2022 Surface Plasmon Resonance Market is estimated to be valued at US$ 910.4 Million in 2022 MARKITWIRED
11-Aug-2022 Over-The-Counter (OTC) Veterinary Drugs Market reach US$ 18.14 Bn by the end of 2032, at a CAGR of 8.1% From 2022-2032 MARKITWIRED
11-Aug-2022 IVD Antibodies Market reaching a valuation of nearly US$ 77 Billion by 2027 MARKITWIRED
11-Aug-2022 Organ Transport Devices Market is set to reach a valuation of US$ 115.1 Mn in 2022 MARKITWIRED
11-Aug-2022 Wireless Surgical Cameras Market is expected to increase at a 7.4% CAGR to reach a valuation of US$ 153.3 Mn by 2032 MARKITWIRED
11-Aug-2022 Organ Transport Devices Market is projected to reach US$ 265.1 Mn by the end of 2032 MARKITWIRED
11-Aug-2022 Hybrid Grafts Market is expected to reach a valuation of US$ 517.3 Mn by the end of 2022 MARKITWIRED
11-Aug-2022 Phakic Intraocular Lenses (IOL) Market is expected to reach US$ 819.5 Million by the end of 2032 MARKITWIRED
11-Aug-2022 INR Test Meter Market is expected to enjoy a valuation of US$ 1.3 Bn by the end of 2022 MARKITWIRED
11-Aug-2022 Global Pharmaceutical Services Outsourcing Market Research Report to 2027 - Featuring Concept Heidelberg, eClinicalWorks, Eurofins Scientific and GMP Pharmaceuticals Among Others - ResearchAndMarkets.com Businesswire
11-Aug-2022 The Worldwide High Potency Active Pharmaceutical Ingredients Industry is Expected to Reach $53 Billion by 2027 - ResearchAndMarkets.com Businesswire
11-Aug-2022 Spatial OMICS Market Intelligence Report - Global Forecast to 2027 - ResearchAndMarkets.com Businesswire
11-Aug-2022 Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer Businesswire
11-Aug-2022 MHRA grants marketing authorisation for Novartis’ radioligand therapy Pluvicto®▼ (lutetium (177Lu) vipivotide tetraxetan) in advanced prostate cancer in Great Britain Novartis
11-Aug-2022 Medicines Discovery Catapult and ZEISS Set Sights on Advancing Microscopy Medicines Discovery Catapult
11-Aug-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
11-Aug-2022 Congenica Announces Partnership With Avesthagen Businesswire
11-Aug-2022 The number of people with higher Covid antibody levels is falling fast, warns testing expert London Medical Laboratory